Patents by Inventor Eric Wieben

Eric Wieben has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080081336
    Abstract: Isolated SLC6A4 nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described. Methods for determining whether a subject contains an SLC6A4 sequence variant also are provided.
    Type: Application
    Filed: August 2, 2007
    Publication date: April 3, 2008
    Inventors: David Mrazek, Richard Weinshilboum, Eric Wieben, Linda Pelleymounter, Irene Moon
  • Publication number: 20070037177
    Abstract: Isolated CYP19A1 nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as CYP19A1 allozymes. Methods for determining the aromatase status of an individual also are provided, as are methods for determining if a subject is predisposed to certain clinical conditions.
    Type: Application
    Filed: August 16, 2005
    Publication date: February 15, 2007
    Inventors: Richard Weinshilboum, Eric Wieben, Oreste Salavaggione, Araba Adjei, Linda Pelleymounter, Josefa Coronel, Liewei Wang, Bruce Eckloff, Daniel Schaid, Cynthia Ma
  • Publication number: 20070015193
    Abstract: Isolated GSTO2 nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as GSTO2 allozymes. Methods for determining if a subject contains a GSTO2 sequence variant also are described.
    Type: Application
    Filed: July 7, 2006
    Publication date: January 18, 2007
    Inventors: Richard Weinshilboum, Baidehi Mukherjee, Linda Pelleymounter, Oreste Salavaggione, Eric Wieben
  • Publication number: 20060188973
    Abstract: Isolated PAPSS1 nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as PAPSS1 allozymes. Methods for determining if a mammal is predisposed to joint disease or cancer also are described.
    Type: Application
    Filed: May 2, 2006
    Publication date: August 24, 2006
    Inventors: Zhenhua Xu, Eric Wieben, Richard Weinshilboum
  • Publication number: 20060134684
    Abstract: Isolated sulfotransferase nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as sulfotransferase allozymes. Methods for determining if a mammal is predisposed to thyroid disease or cancer also are described.
    Type: Application
    Filed: February 6, 2006
    Publication date: June 22, 2006
    Inventors: Robert Freimuth, Eric Wieben, Richard Weinshilboum
  • Publication number: 20050277153
    Abstract: Isolated sulfotransferase nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as sulfotransferase allozymes. Methods for determining if a mammal is predisposed to a heart condition or cancer also are described.
    Type: Application
    Filed: July 12, 2005
    Publication date: December 15, 2005
    Inventors: Bianca Thomae, Eric Wieben, Richard Weinshilboum